HC Wainwright & Co. Reiterates Buy on Korro Bio, Maintains $100 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Buy rating on Korro Bio (NASDAQ:KRRO) and maintained a price target of $100.
January 19, 2024 | 11:35 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Mitchell Kapoor reaffirmed a Buy rating on Korro Bio with a price target of $100.
The reiteration of a Buy rating and a high price target by a reputable analyst like Mitchell Kapoor can lead to increased investor confidence and potentially drive up the stock price in the short term. The specific mention of the $100 price target suggests a significant upside potential from the current trading level, assuming the stock is trading below that target.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100